Decolonization to Reduce After-Surgery Events of Surgical Site Infection

NCT05586776 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

2700

Enrollment

OTHER

Sponsor class

Conditions

Surgical Site Infection

Interventions

DRUG: 4% Chlorhexidine Gluconate
DRUG: 2% Mupirocin
DRUG: Soap Without Antiseptic Properties (Placebo)
DRUG: Placebo Nasal Ointment

Sponsor

University of California, Irvine

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]